Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL Scan: Tofacitinib in RA on Background Methotrexate
NCT00847613Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Mar 2009; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00847613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847613.